Nomura Asset Management Co. Ltd. increased its position in Humana Inc. (NYSE:HUM – Free Report) by 5.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 43,920 shares of the insurance provider’s stock after acquiring an additional 2,242 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Humana were worth $11,249,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Montag A & Associates Inc. boosted its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its stake in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Fideuram Asset Management Ireland dac bought a new position in Humana during the 4th quarter valued at about $27,000. Rosenberg Matthew Hamilton lifted its stake in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Finally, Larson Financial Group LLC lifted its stake in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares during the period. Institutional investors own 92.38% of the company’s stock.
Analyst Ratings Changes
HUM has been the topic of several research analyst reports. Wells Fargo & Company cut shares of Humana from a “cautious” rating to a “reduce” rating in a research note on Wednesday, May 20th. UBS Group upped their target price on shares of Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Robert W. Baird lowered their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Finally, TD Cowen upped their price target on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research report on Friday, May 1st. Nine equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $272.65.
Humana Price Performance
NYSE HUM opened at $320.57 on Wednesday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $333.31. The firm has a market capitalization of $38.49 billion, a P/E ratio of 34.29, a PEG ratio of 2.38 and a beta of 0.76. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $235.19 and a 200-day moving average price of $229.58.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts anticipate that Humana Inc. will post 9 earnings per share for the current year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is currently 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
